Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.43 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.43 |
| ▸ | SPHK2 | Q9NRA0 | 7/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 7/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 4/20 | 0.42 |
| ▸ | RAB9A | P51151 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25914443 | 0.97 | MAPT (0.46) | MAPTTSHRNOTUMHSD11B1HSD11B2 | |
| SCHEMBL24987407 | 0.95 | SPHK2 (0.47) | MAPTTSHRNOTUMSPHK2SPHK1 | |
| SCHEMBL24987982 | 0.88 | TSHR (0.48) | MAPTTSHRNOTUMHSD11B1HSD11B2 | |
| SCHEMBL31682248 | 0.87 | SPHK2 (0.43) | SPHK2SPHK1NPC1RAB9AL3MBTL1 | |
| SCHEMBL24988518 | 0.86 | MAPT (0.43) | MAPTTSHRNOTUMSPHK2SPHK1 | |
| SCHEMBL24989004 | 0.85 | TSHR (0.48) | MAPTTSHRNOTUMHSD11B1HSD11B2 | |
| SCHEMBL25914441 | 0.85 | MAPT (0.46) | MAPTTSHRNOTUMDPP4DPP7 | |
| SCHEMBL31682252 | 0.84 | KIT (0.46) | SPHK2SPHK1NPC1RAB9A | |
| SCHEMBL25914367 | 0.82 | TSHR (0.50) | MAPTTSHRNOTUMHSD11B1HSD11B2 | |
| SCHEMBL24988632 | 0.81 | KIT (0.52) | SPHK2SPHK1NPC1RAB9ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624011-B2 | Oxadiazole derivative | Sumitomo Pharma Co., Ltd. (JP) | 2026-05-12 | — | — | US | claimed |
| EP-4122923-B1 | OXADIAZOLE DERIVATIVE | SUMITOMO PHARMA CO LTD (JP) | 2025-09-10 | — | — | EP | claimed |
| US-20230265061-A1 | OXADIAZOLE DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2023-08-24 | — | — | US | claimed |
| EP-4122923-A1 | OXADIAZOLE DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2023-01-25 | — | — | EP | claimed |
| CN-115515943-A | Oxadiazole derivatives | 住友制药株式会社 | 2022-12-23 | — | — | CN | claimed |
| US-12624011-B2 | Oxadiazole derivative | Sumitomo Pharma Co., Ltd. (JP) | 2026-05-12 | — | — | US | disclosed |
| CN-115515943-B | Oxadiazole derivatives | 住友制药株式会社 | 2024-07-09 | — | — | CN | disclosed |
| US-20230265061-A1 | OXADIAZOLE DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2023-08-24 | — | — | US | disclosed |
| US-20230265061-A1 | OXADIAZOLE DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2023-08-24 | — | — | US | disclosed |
| US-20230265061-A1 | OXADIAZOLE DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2023-08-24 | — | — | US | disclosed |
| US-11718592-B2 | Oxadiazole derivative | Sumitomo Pharma Co., Ltd. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-11718592-B2 | Oxadiazole derivative | Sumitomo Pharma Co., Ltd. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-11718592-B2 | Oxadiazole derivative | Sumitomo Pharma Co., Ltd. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-20230092498-A1 | OXADIAZOLE DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2023-03-23 | — | — | US | disclosed |
| EP-4122923-A1 | OXADIAZOLE DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2023-01-25 | — | — | EP | disclosed |
| EP-4122923-A1 | OXADIAZOLE DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2023-01-25 | — | — | EP | disclosed |
| CN-115515943-A | Oxadiazole derivatives | 住友制药株式会社 | 2022-12-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230092498-A1 | OXADIAZOLE DERIVATIVE | OXA1L, SCN1A, CACNA1A | MAPT 1620/4885TSHR 2480/4885NOTUM 3472/4885 |
| US-11718592-B2 | Oxadiazole derivative | OXA1L, SCN1A, CACNA1A | MAPT 1620/4885TSHR 2480/4885NOTUM 3472/4885 |
| US-20230265061-A1 | OXADIAZOLE DERIVATIVE | OXA1L, SCN1A, CACNA1A | MAPT 1620/4885TSHR 2480/4885NOTUM 3472/4885 |
| US-12624011-B2 | Oxadiazole derivative | HSD3B1, CBR3, CBR1 | MAPT 4111/4885TSHR 1451/4885NOTUM 2781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.